racemetirosine has been researched along with Syndrome in 3 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Syndrome: A characteristic symptom complex.
Excerpt | Relevance | Reference |
---|---|---|
"He had a negative evaluation for malignant hyperthermia (MH), and we suggest that NMS differs from MH." | 1.26 | Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. ( Burke, RE; Fahn, S; Louis, K; Mayeux, R; Weinberg, H; Willner, JH, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Staedtke, V | 1 |
Bai, RY | 1 |
Kim, K | 1 |
Darvas, M | 1 |
Davila, ML | 1 |
Riggins, GJ | 1 |
Rothman, PB | 1 |
Papadopoulos, N | 1 |
Kinzler, KW | 1 |
Vogelstein, B | 1 |
Zhou, S | 1 |
Burke, RE | 1 |
Fahn, S | 1 |
Mayeux, R | 1 |
Weinberg, H | 1 |
Louis, K | 1 |
Willner, JH | 1 |
Jacquet, Y | 1 |
3 other studies available for racemetirosine and Syndrome
Article | Year |
---|---|
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.
Topics: alpha-Methyltyrosine; Animals; Atrial Natriuretic Factor; Catecholamines; CD3 Complex; Cytokines; Ep | 2018 |
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
Topics: Adolescent; Adult; alpha-Methyltyrosine; Antipsychotic Agents; Child; Dopamine; Dystonia; Female; Fe | 1981 |
A dystonia-like syndrome after neuropeptide (MSH/ACTH) stimulation of the rat locus ceruleus.
Topics: Adrenocorticotropic Hormone; alpha-Methyltyrosine; Animals; Dose-Response Relationship, Drug; Dyston | 1988 |